DK260987D0 - Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden

Info

Publication number
DK260987D0
DK260987D0 DK260987A DK260987A DK260987D0 DK 260987 D0 DK260987 D0 DK 260987D0 DK 260987 A DK260987 A DK 260987A DK 260987 A DK260987 A DK 260987A DK 260987 D0 DK260987 D0 DK 260987D0
Authority
DK
Denmark
Prior art keywords
procedure
exercising
preparing
dna sequence
human protein
Prior art date
Application number
DK260987A
Other languages
Danish (da)
English (en)
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Priority to DK260987A priority Critical patent/DK260987D0/da
Publication of DK260987D0 publication Critical patent/DK260987D0/da
Priority to PCT/DK1988/000082 priority patent/WO1988009384A1/fr
Priority to JP63504682A priority patent/JP3011274B2/ja
Priority to ES8801999A priority patent/ES2013337A6/es
Priority to EP88904935A priority patent/EP0362259B1/fr
Priority to AU19399/88A priority patent/AU619750B2/en
Priority to DE3855078T priority patent/DE3855078T2/de
Priority to AT88904935T priority patent/ATE135049T1/de
Priority to IL8647688A priority patent/IL86476A/en
Priority to CA000567916A priority patent/CA1340862C/fr
Priority to NO890260A priority patent/NO301985B1/no
Priority to FI895553A priority patent/FI102191B1/fi
Priority to DK583589A priority patent/DK164283C/da
Priority to US07/929,290 priority patent/US5432264A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK260987A 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden DK260987D0 (da)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden
AT88904935T ATE135049T1 (de) 1987-05-22 1988-05-20 Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
DE3855078T DE3855078T2 (de) 1987-05-22 1988-05-20 Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
JP63504682A JP3011274B2 (ja) 1987-05-22 1988-05-20 組み換え技術により産生した、３−デス−ヒドロキシ−シスタチンｃポリペプチドまたはその修飾物
ES8801999A ES2013337A6 (es) 1987-05-22 1988-05-20 Metodo de producir cistatina c.
EP88904935A EP0362259B1 (fr) 1987-05-22 1988-05-20 Procede de production de cystatine c ou modifications de la cystatine et sequence d'adn destinee a etre utilisee lors de la realisation dudit procede
AU19399/88A AU619750B2 (en) 1987-05-22 1988-05-20 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method
PCT/DK1988/000082 WO1988009384A1 (fr) 1987-05-22 1988-05-20 Procede de production de cystatine c ou modifications de la cystatine et sequence d'adn destinee a etre utilisee lors de la realisation dudit procede
IL8647688A IL86476A (en) 1987-05-22 1988-05-23 A method for producing a polypeptide having human cysteine C activity and AND sequence for performing this method
CA000567916A CA1340862C (fr) 1987-05-22 1988-05-24 Methode pour la production d'une proteine humaine et sequence d'adn utilisee pour appliquer la methode
NO890260A NO301985B1 (no) 1987-05-22 1989-01-20 Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten
FI895553A FI102191B1 (fi) 1987-05-22 1989-11-21 Menetelmä 3-des-hydroksikystatiini C:n tuottamiseksi ja menetelmässä käytettävä DNA-sekvenssi
DK583589A DK164283C (da) 1987-05-22 1989-11-21 Polypeptid med cystatin c aktivitet, dna-sekvens til udtrykkelse af 3-des-oh-cystatin c eller en modifikation deraf, fremgangsmaade til fremstilling af 3-des-hydroxy-cystatin c eller en modifikation deraf, plasmid og mikroorganisme til udoevelse af fremgangsmaaden og anvendelse af 3-des-oh-cystatin c eller en modifikation deraf til fremstilling af et terapeutisk praeparat
US07/929,290 US5432264A (en) 1987-05-22 1992-08-13 Recombinant 3-des-OH-cystatin C produced by expression in a procaryotic host cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden

Publications (1)

Publication Number Publication Date
DK260987D0 true DK260987D0 (da) 1987-05-22

Family

ID=8113675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden

Country Status (12)

Country Link
EP (1) EP0362259B1 (fr)
JP (1) JP3011274B2 (fr)
AT (1) ATE135049T1 (fr)
AU (1) AU619750B2 (fr)
CA (1) CA1340862C (fr)
DE (1) DE3855078T2 (fr)
DK (1) DK260987D0 (fr)
ES (1) ES2013337A6 (fr)
FI (1) FI102191B1 (fr)
IL (1) IL86476A (fr)
NO (1) NO301985B1 (fr)
WO (1) WO1988009384A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002820A1 (fr) * 1988-11-18 1990-05-18 Kazunori Hanada Utilisation des cystatines en pharmacie
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
RU2182598C2 (ru) * 1994-11-21 2002-05-20 Новартис Аг Модифицированные ингибиторы протеиназы
AU738766B2 (en) * 1994-11-21 2001-09-27 University Of Leeds, The Modified proteinase inhibitors
EP0842187A4 (fr) * 1995-06-05 2000-04-12 Human Genome Sciences Inc Cystatine e humaine
US6011012A (en) 1995-06-05 2000-01-04 Human Genome Sciences, Inc. Human cystatin E
EP1123399A2 (fr) * 1998-08-05 2001-08-16 The University Of British Columbia Production et utilisation de cystatines modifiees
US6436389B1 (en) * 1998-12-11 2002-08-20 The Salk Institute For Biological Studies Stimulation of cell proliferation by glycosylated cystatin C
EP1176200A3 (fr) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Utilisation des polypeptides ou leurs acides nucléiques pour le diagnose ou traitement des maladies de la peau ou de la cicatrisation de blessures et leurs utilisations pour l'identification des substances pharmacologiquement actives
EP2880994B1 (fr) * 2012-07-31 2017-06-28 Megmilk Snow Brand Co. Ltd. Nouvelle substance protéique
CN102895658A (zh) * 2012-08-23 2013-01-30 苏州大学附属第一医院 Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) * 2016-08-10 2016-11-16 吴江近岸蛋白质科技有限公司 表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
DE3855078T2 (de) 1996-07-18
NO301985B1 (no) 1998-01-05
JP3011274B2 (ja) 2000-02-21
WO1988009384A1 (fr) 1988-12-01
IL86476A0 (en) 1988-11-15
AU619750B2 (en) 1992-02-06
FI895553A0 (fi) 1989-11-21
IL86476A (en) 1994-01-25
ES2013337A6 (es) 1990-05-01
JPH03501201A (ja) 1991-03-22
EP0362259B1 (fr) 1996-03-06
ATE135049T1 (de) 1996-03-15
NO890260L (no) 1989-01-20
EP0362259A1 (fr) 1990-04-11
AU1939988A (en) 1988-12-21
NO890260D0 (no) 1989-01-20
FI102191B (fi) 1998-10-30
DE3855078D1 (de) 1996-04-11
CA1340862C (fr) 1999-12-28
FI102191B1 (fi) 1998-10-30

Similar Documents

Publication Publication Date Title
DK639689D0 (da) Indfoering af dna i celler
DK260987D0 (da) Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden
AU4159185A (en) Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelets with vessel walls
DE3856301D1 (de) Dns sequenzen, rekombinante dns-moleküle sowie verfahren zur herstellung des an der lymphocyten-funktion assoziierten antigens-3
DE3885151D1 (de) Methode zur Herstellung von Methacrylatestern.
DE3789428T2 (de) Mikroorganismen, fähig zur Laktoseassimilation.
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
ES8706827A1 (es) Procedimiento para preparar polipeptidos.
JPS6430588A (en) Foreign dna developing promoter n methylotroph bacteria, its production and use
DE3864512D1 (de) Verfahren zur herstellung von kandis mit gepressten gaszellen.
DK161487D0 (da) Alfa-interferon-analoge og fremgangsmaade til fremstilling deraf samt udtrykkelsesvektorer og vaertsorganismer til anvendelse ved fremgangsmaaden.
DK135688A (da) Fremgangsmaade til isolering af basalmembranproteiner fra vaev fra mennesker og dyr
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DK583589A (da) Fremgangsmaade til fremstilling af cystatin c eller modifikationer heraf og dna-sekvens til brug ved udoevelse af fremgangsmaaden
DE3688225D1 (de) Herstellung menschlichen somatomedins c.
DK608389A (da) Fremgangsmaade til aerob fermentering under udvinding af carbondioxid samt fermentor til udoevelse af fremgangsmaaden
BR8506737A (pt) Valvula cardiaca biologica e processo de construcao
RO95736A2 (fr) Procede de controle biologique des oeufs pendant le processus d'incubation
PL263624A1 (en) Biological sewage treatment plant
PL267369A1 (en) Biological sewage treatment plant
PL267042A2 (en) Biological sewage treatment method

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment